Assessment of Sleep Quality in Patients Utilizing Cannabinoid Therapy
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 34
- 试验地点
- 1
- 主要终点
- Change in Sleep Quality (Pittsburgh Sleep Quality Index)
研究概览
简要总结
The current study aims to assess the impact of starting cannabinoid therapy on sleep quality for individuals with sleep disturbance.
详细描述
After the initial signing of the consent form, they will complete a battery of baseline questionnaires online on sleep, including the Sleep Regularity Questionnaire, Epworth Sleepiness Scale, Insomnia Severity Index, and the Depression, Anxiety, Stress Scale (DASS-21). That night, before beginning active treatment, participants will be monitored using Cerebra's Level 2 plus ECG system (the Prodigy).
After 6 weeks of active treatment, participants will again complete a night of Level 2 plus ECG recording using the Prodigy, evening, and morning questionnaires, and will repeat baseline sleep questionnaires.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 40 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Change in Sleep Quality (Pittsburgh Sleep Quality Index)
时间窗: 6 weeks
Change in Objective Sleep Quality (Odds Ratio Product)
时间窗: 6 weeks
次要结局
未报告次要终点